Skip to main content
2024 ACTOX Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Sunday, November 17, 2024
  • 7:00 AM – 8:00 AM CT
    CE Continental Breakfast
  • 7:00 AM – 8:00 AM CT
    New Member Mingle and VIP Breakfast
  • 7:00 AM – 6:00 PM CT
    Registration Open 
  • 8:00 AM – 11:30 AM CT
    Regulatory Toxicology Case Studies: An Interactive Session Involving Industry, CRO, Consultant and Regulatory Perspectives (CE1)
    CE Course Chair: Simon Authier, DVM, MBA, PhD, DSP – Charles River Laboratories
    CE Course Chair: Katie B. Sokolowski, PhD, DABT – Denali Therapeutics
    CE Course Speaker: Denis Roy, PhD – SciLucent, Inc.
    CE Course Speaker: Armaghan Emami, PharmD, PhD – US FDA
    CE Course Speaker: Paramita Mookherjee, PhD, DABT – Regeneron
    CE Course Speaker: Wendy Haines, PhD, DABT, ERT – PharmEng Technology
    AdvancedPractical
  • 8:00 AM – 11:30 AM CT
    Fundamentals of Nonclinical Toxicology Study Pathology Reports, Peer Reviews, and Working Groups for Toxicologists and Regulators (CE2)
    CE Course Chair: Tom Steinbach, DVM, DACVP, DABT – EPL, Inc.
    CE Course Chair: Daniel Patrick, DVM, DACVP, DABT – Eli Lilly and Company, Inc.
    CE Course Speaker: Deb Tokarz, DVM, PhD, DACVP – EPL, Inc.
    CE Course Speaker: Paul Snyder, DVM, DACVP, PhD – EPL, Inc.
    CE Course Speaker: Ines Pagan, DVM, PhD – US FDA
    Foundational (Basic)Practical
  • 8:00 AM – 11:30 AM CT
    The Use of Novel Tools in Nonclinical Safety to Advance Drug Discovery and Early Development (CE3)
    CE Course Chair: Patricia Ryan, PhD – AstraZeneca
    CE Course Chair: Julia Johansson, PhD – AstraZeneca
    CE Course Speaker: Serah Kang, PhD – Genentech, Inc.
    CE Course Speaker: Wen Sun, PhD – Pfizer
    CE Course Speaker: Brian Vega, PhD – Merck
    CE Course Speaker: Nakissa Sadrieh, PhD – US FDA
    AdvancedEmerging
  • 8:00 AM – 11:30 AM CT
    Safety Considerations for the Evaluation of Lipid-Based Nanoparticles (CE4)
    CE Course Chair: Elena Braithwaite, DABT – US FDA
    CE Course Chair: Emily Place, PhD – Aclairo Pharmaceutical Development Group, Inc.
    CE Course Speaker: David W. Hobson, PhD, DABT – LoneStar PharmTox, LLC
    CE Course Speaker: Jonathan A. Phillips, PhD – Intellia Therapeutics
    CE Course Speaker: Olen Stephens, PhD – US FDA
    CE Course Speaker: Jessica Sutherland, PhD, DABT – Alnylam Pharmaceuticals
    Foundational (Basic)Practical
  • 11:00 AM – 4:00 PM CT
    Speaker Ready Room Open 
  • 11:45 AM – 12:55 PM CT
    IJT Editorial Board Meeting
  • 12:00 PM – 12:55 PM CT
    (EHP) Altasciences—Juvenile Nonhuman Primates for Gene Therapy Research: Use of Immunopathology Data to Adjust Testing Ages and the 3Rs
  • 12:00 PM – 12:55 PM CT
    (EHP) Certara—Real-Time Nonclinical Study Data: Benefits, Logistics, and Data Analysis and Visualization
  • 12:00 PM – 12:55 PM CT
    (EHP) Inotiv—Assessing the Genotoxic Potential of Lipid Nanoparticles (LNPs): Inotiv's In Vitro Study Experience
  • 12:00 PM – 12:55 PM CT
    (EHP) Lovelace Biomedical Research Institute—Challenges and Opportunities in Nonclinical Intranasal Drug Delivery
  • 1:00 PM – 4:30 PM CT
    Translational Challenges from Nonclinical to Clinical Program: Case Study Examples (CE5)
    CE Course Chair: Deven Dandekar, PhD – Eli Lilly and Company, Inc.
    CE Course Chair: August Wilke, PhD, DABT – Eli Lilly and Company, Inc.
    CE Course Speaker: Deepa B. Rao, PhD, DABT, DACVP, FIATP – Greenfield Pathology Services, Inc.
    CE Course Speaker: David B. Hawver – Hawver Nonclinical Consulting, LLC
    CE Course Speaker: Bhanu Singh, DACVP, DABT, FIATP – Gilead Sciences Inc.
    Foundational (Basic)Practical
  • 1:00 PM – 4:30 PM CT
    Toxicologic Neuropathology of Novel Therapeutics (CE6)
    CE Course Chair: Dinesh S. Bangari, PhD, DACVP – Sanofi
    CE Course Chair: Lisa Lanigan, DVM, PhD, DACVP – Charles River Laboratories
    CE Course Speaker: Sarah Cramer, DVM, PhD, DACVP – StageBio
    CE Course Speaker: Elizabeth Galbreath, DVM, PhD, DACVP – Advanced Pathology Solutions
    CE Course Speaker: Jessica Grieves, DVM, PhD, ACVP – Ionis Pharmaceuticals
    CE Course Speaker: René Meisner, DVM, DACVP, DABT – TCG Labs Soleil
    CE Course Speaker: Arlin B. Rogers, DVM, PhD, DACVP – Alnylam Pharmaceuticals
    CE Course Speaker: Brad Bolon, DVM, PhD – GEMpath, Inc.
    AdvancedPractical
  • 1:00 PM – 4:30 PM CT
    Nonclinical Immunotoxicity Assessment: State of the Science and Future Directions (CE7)
    CE Course Chair: David McMillan, PhD, DABT – US FDA
    CE Course Chair: Gary R. Burleson, PhD – Burleson Research Technologies, Inc.
    CE Course Speaker: Gautham K. Rao, PhD, DABT – Genentech, Inc.
    CE Course Speaker: Kristina Howard, DVM, PhD – US FDA
    CE Course Speaker: Carmen Booker, PhD – US FDA
    CE Course Speaker: Jamie DeWitt, PhD, DABT – Oregon State University
    Foundational (Basic)Emerging
  • 1:00 PM – 4:30 PM CT
    Toxicological Assessment of Pharmaceutical Impurities (CE8)
    CE Course Chair: Catrin Hasselgren, PhD – Genentech
    CE Course Chair: Alessandro Brigo, PhD, ERT, DABT – Roche Pharma Research & Early Development
    CE Course Speaker: Jessica Graham, PhD, DABT, ATS – Genentech Inc
    CE Course Speaker: Michelle Kenyon, MA – Pfizer Research and Development
    CE Course Speaker: Joel Bercu, PhD, MPH, DABT – Gilead Sciences, Inc.
    CE Course Speaker: Jennifer Alleva, PhD – Gilead Sciences, Inc.
    Foundational (Basic)Practical
  • 2:00 PM – 6:30 PM CT
    Exhibition and Poster Setup
  • 4:45 PM – 6:30 PM CT
    Student Poster Competition
  • 7:00 PM – 8:30 PM CT
    Welcome Reception